The full name of Hetropapa is Hetropapa Ethanolamine Tablets, which acts on the thrombopoietin receptor and can be used in adult patients with chronic primary immune thrombocytopenia that has responded poorly to immunoglobulin, glucocorticoids, and other therapies, and severe aplastic anemia that has failed to respond to immunosuppressive therapies. Adverse reactions such as headache, diarrhea, thrombosis, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated platelet counts, and elevated blood bilirubin may be observed with this drug. The drug should be administered on an empty stomach and food should not be consumed until 2 hours after administration. The drug may interact with statins when used in combination. It is contraindicated for those who are allergic to the drug. Nursing women should stop breastfeeding if needed. If you need to use the drug, please strictly follow the doctor’s instruction to take the drug, do not self-medication.